Bridging the Digital Divide to Advance Bio/Pharma Manufacturing and Quality: A Technology Forum

INTERPHEX

Webcast

*Tuesday, May 25, 2021 at 10am EDT* The bio/pharma industry is turning to proven digital technologies used in other industries to plan, develop, and monitor manufacturing processes, as well as in quality, training, and regulatory oversight. In this event, experts discuss how artificial intelligence, remote monitoring, digital twins, and other technologies can be applied to modernize bio/pharma processes and systems. Lessons learned from the pandemic will be shared. *On Demand Until May 25, 2022*

Register free: https://www.pharmtech.com/pt_w/interphex2

Event Overview:

The bio/pharma industry is turning to proven digital technologies used in other industries to plan, develop, and monitor manufacturing processes, as well as in quality, training, and regulatory oversight. In this event, experts discuss how artificial intelligence, remote monitoring, digital twins, and other technologies can be applied to modernize bio/pharma processes and systems. Lessons learned from the pandemic will be shared.

Agenda:

Session 1 - 10-11:15am EDT

Digitalization: Moving from Theory to Practice

The use of digital technologies for bio/pharmaceutical process development, manufacturing, quality control, and general operations sounds promising. What are the challenges in putting these innovations into practice in a regulated environment? Experts will share insights and experience in moving digital concepts into practice.

  • What bio/pharma can learn from practices in other industries
  • Improving product quality with digital tools for the lab and manufacturing facility
  • The role of AI, analytics, and digital twins in the facility of the future
  • Remote auditing pitfalls and best practices
  • Using virtual inspection tools for evaluating vendors and manufacturing facilities

Panelists:

  • Evgeniya Makarova, partner, McKinsey & Company
  • Ulf Schrader, senior partner, McKinsey & Company
  • Peter Miller, principal partner, Dynamic Compliance Solutions
  • Chris Alden, associate director, global CGMP auditing and compliance, Merck

Session 2 - 11:20am-1pm EDT

Sponsored Sessions

Session 3 - 1-2pm EDT

Harnessing Digitalization Technologies in Pharma Manufacturing

Pharmaceutical manufacturers are moving towards digital maturity, enabled by increasing levels of connectivity and availability of digital technologies tailored for the pharmaceutical industry. Digitalization benefits process design and development, as well as operations. Hear experts discuss current trends, benefits and challenges of adopting Pharma 4.0 technologies, and lessons to be learned from other industries for all areas of pharmaceutical manufacturing.

Hear expert insight on key pharmaceutical process development and manufacturing topics:

  • Digital maturity models
  • Digital tools for facility and process design
  • Simulation and digital twins for scaleup and tech transfer
  • Predictive maintenance
  • Planning a digital transformation

Panelists:

Yvonne Duckworth, PE, registered automation engineer, CRB

Harbinder Pordal, principal consultant, Stress Engineering

Time and Date: Thursday, May 25, 2021, 10am EDT

On demand available after final airing until May 25, 2022

Register free: https://www.pharmtech.com/pt_w/interphex2